Clinical Trials Logo

ANAKINRA Treatment clinical trials

View clinical trials related to ANAKINRA Treatment.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04364009 Terminated - COVID-19 Infection Clinical Trials

Anakinra for COVID-19 Respiratory Symptoms

ANACONDA
Start date: April 27, 2020
Phase: Phase 3
Study type: Interventional

The main objective of the ANACONDA-COVID-19 trial is to assess the efficacy of Anakinra + optimized Standard of Care (oSOC) as compared to oSOC alone on the condition of patients with COVID-19 infection and worsening respiratory symptoms. Success defined as patient alive and free of invasive mechanical ventilation (IMV) and free of Extracorporeal Membrane Oxygenation (ECMO) at Day 14.